Sanofi: shareholders and insiders

SNYNASDAQHealthcare · Pharmaceutical Preparations

Price

$46.79

November 20, 2026Market cap $114B

What Ploutos Investor adds for Sanofi

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 11 fiscal years, from 2015
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

2 Form 4s

Sorry, we do not have enough data

for purchases and sales by Sanofi's insiders

Why?

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

2 Holders over 5%Oct 26, 2026 Latest filing
  • BlackRock, Inc.
    Share of class5.80%
  • Amundiwith 1 more person
    Share of class5.70%

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter+225%
  • Millennium Mgmt (Englander)
    In the quarter+50%
  • Bridgewater (Dalio)
    In the quarter+107%
  • Citadel Advisors (Griffin)
    In the quarter-59%
  • AQR Capital
    In the quarter+24%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short sales in daily trading

How much of the shares that changed hands were short sales, in the off-exchange trades brokers report each day.

20.6% the last 14 sessions+7.4 pts vs the 14 before

In the last 14 sessions, 20.6% of the shares in the reported trades were short sales, against 13.2% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
20.6%
The 14 beforeOct 13, 2026 – Oct 30, 2026
13.2%
Change
+7.4 pts
Short sales a dayon average, of 1.84M shares
379.1K
More than atof 3,666 US-listed companies, same days
1%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 14.8%
  • Oct 14, 2026: Short sales 13.1%
  • Oct 15, 2026: Short sales 12.3%
  • Oct 16, 2026: Short sales 12.4%
  • Oct 19, 2026: Short sales 5.7%
  • Oct 20, 2026: Short sales 12.1%
  • Oct 21, 2026: Short sales 8.2%
  • Oct 22, 2026: Short sales 17.8%
  • Oct 23, 2026: Short sales 12.8%
  • Oct 26, 2026: Short sales 27.7%
  • Oct 27, 2026: Short sales 17.1%
  • Oct 28, 2026: Short sales 29.3%
  • Oct 29, 2026: Short sales 26.8%
  • Oct 30, 2026: Short sales 7%
  • Nov 2, 2026: Short sales 19.1%
  • Nov 3, 2026: Short sales 19.5%
  • Nov 4, 2026: Short sales 20.1%
  • Nov 5, 2026: Short sales 6.8%
  • Nov 6, 2026: Short sales 29.5%
  • Nov 9, 2026: Short sales 28.1%
  • Nov 10, 2026: Short sales 26.2%
  • Nov 11, 2026: Short sales 22.3%
  • Nov 12, 2026: Short sales 30%
  • Nov 13, 2026: Short sales 20.7%
  • Nov 16, 2026: Short sales 34.4%
  • Nov 17, 2026: Short sales 24.3%
  • Nov 18, 2026: Short sales 20.9%
  • Nov 19, 2026: Short sales 29.6%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half. Shares held short, which are published twice a month, are not included here.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

38 ETFs holding it4.00% The largest weight (PPH)
  • PPHVanEck Pharmaceutical ETF
    Weight in the fund4.00%
  • FEZState Street(R) SPDR(R) EURO STOXX 50(R) ETF
    Weight in the fund1.91%
  • EZUiShares MSCI Eurozone ETF
    Weight in the fund1.23%
  • IVLUiShares MSCI Intl Value Factor ETF
    Weight in the fund1.23%
  • IXJiShares Global Healthcare ETF
    Weight in the fund1.18%
  • LVHIFranklin International Low Volatility High Dividend Index ETF
    Weight in the fund1.18%
  • FENIFidelity Enhanced International ETF
    Weight in the fund0.91%
  • EFViShares MSCI EAFE Value ETF
    Weight in the fund0.84%
  • JIREJPMorgan International Research Enhanced Equity ETF
    Weight in the fund0.75%
  • EFAViShares MSCI EAFE Min Vol Factor ETF
    Weight in the fund0.71%

38 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

715 Managers, Q2 2026$8.1B Value of their positions
  • Q3 2025: Managers 712
  • Q4 2025: Managers 758
  • Q1 2026: Managers 746
  • Q2 2026: Managers 715

Institutional investors by quarter

The fund managers holding SNY, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 715 managers held 190M shares, worth $8.1B. During the quarter 88 opened a position, 119 closed one, 212 added and 292 trimmed.

The largest holders, Q2 2026

  • Dodge & Cox
    In the quarter-4.8%
  • Morgan Stanley
    In the quarter-14%
  • Fisher Asset Management
    In the quarter-7.1%
  • Bank of America
    In the quarter-16%
  • Invesco
    In the quarter+2.7%
  • JPMorgan Chase
    In the quarter+17%
  • Mondrian Investment Partners
    In the quarter+9.6%
  • Brandes Investment Partners
    In the quarter+11%
  • Federated Hermes
    In the quarter-19%
  • Boston Partners
    In the quarter+6.8%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Sanofi's filings show?

Who buys and sells is one part of Sanofi's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SNY's shareholders

Didn't find what you were looking for?

Ask us
Have SNY's insiders bought or sold?

From Aug 7, 2026 to Aug 12, 2026 Sanofi's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold SNY?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $231M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.